carmot glp 1 Patent and Innovation Trends in GLP-1 and Weight Loss Drugs (2020–2025) GLP-1 boom causing pharma FOMO
Description
This is exhausting, especially in the first months
10.1093/ejendo/lvad110 Eur J Endocrinol
When combined, appetite suppression may be more pronounced, which can actually be beneficial for weight loss goals but requires monitoring to ensure adequate nutrition
they are not suitable for everyone and may have risks
It is not a diagnostic device or a substitute for medical supervision
